Exploring New Models For Rare Disease Drug Development And Commercialisation
Let's dive into the details surrounding New Models For Rare Disease Drug Development And Commercialisation.
- Clare Thibodeaux, Ph.D, MBA, Director of Scientific Affairs, Cures Within Reach | Advancing
- Value of Integrated Data and Analytics in
- Drug development
- Introducing the "
- Data Sharing and Analysis to Support
In-Depth Information on New Models For Rare Disease Drug Development And Commercialisation
Speakers: Sara Brightwell-Muir (LifeArc), Stefano Benvenuti (Fondazione Telethon ETS) and Craig Martin (Orphan Therapeutics ... C-Path's Endpoints in Rachel Smith, Executive Director,
Are you passionate about making a difference in the fields of neurology and
That wraps up our extensive overview of New Models For Rare Disease Drug Development And Commercialisation.
